Abstract
Bromotryptophan is a nonstandard amino acid that is rarely incorporated in ribosomally synthesized and post-translationally modified peptides (ribosomal peptides). Bromotryptophan and its analogs sometimes occur in non-ribosomal peptides. This paper presents an overview of ribosomal and non-ribosomal peptides that are known to contain bromotryptophan and its analogs. This work further covers the biological activities and therapeutic potential of some of these peptides.
Keywords: Bromotryptophan and analogs, nonstandard amino acid, proteinogenic and non-proteinogenic amino acids, bromotryptophan- containing peptide, ribosomal and non-ribosomal peptides, conotoxin/conopeptide.
Graphical Abstract
[1]
Ambrogelly, A.; Palioura, S.; Soll, D. Natural expansion of the genetic code. Nat. Chem. Biol., 2007, 3, 29-35.
[2]
Arnison, P.G.; Bibb, M.J.; Bierbaum, G.; Bowers, A.A.; Bugni, T.S.; Bulaj, G.; Camarero, J.A.; Campopiano, D.J.; Challis, G.L.; Cardy, J.; Cotter, P.D.; Craik, D.J.; Dawson, M.; Dittmann, E.; Donadio, S. Dorrestein. C.; Entian, K.D.; Fischbach, M.A.; Garavelli, J.S.; Goransson, U.; Gruber, C.W.; Haft, D.H.; Hemscheidt, T.K.; Hertweck, C.; Hill, C.; Horswill, A.R.; Jaspars, M.; Kelly, W.L.; Klinman, J.P.; Kuipers, O.P.; Liu, W.; Marahiel, M.A.; Mitchell, D.A.; Moll, G.N.; Moore, B.S.; Muller, R.; Nair, S.K.; Nes, I.F.; Norris, G.E.; Olivera, B.M.; Onaka, H.; Patchett, M.L.; Piel, J.; Keaney, M.J.; Rebuffat, S.; Ross, R.P.; Sahl, H.G.; Schmidt, E.W.; Selsted, M.E.; Severinov, K.; Shen, B.; SivonenK.; Smith, L.; Stin, T.; Sussmuth, R.D.; Tagg, J.R.; Tang, G.L.; Truman, A.W.; Vedera, J.C.; Walsh, C.T.; Walton, J.D.; Wenzel, S.C.; Willey, J.M.; van der Donk, W.A. Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature. Nat. Prod. Rep., 2013, 30, 108-160.
[5]
Terlau, H.; Olivera, B.M. Conus venoms: A rich source of novel ion channel-targeted peptides. Physiol. Rev., 2004, 84, 41-68.
[6]
Olivera, B.M. Conus peptides: Biodiversity-based discovery and exogenomics. J. Biol. Chem., 2006, 281, 31173-31177.
[7]
Olivera, B.M.; Rivier, J.; Clark, C.; Ramilo, C.A.; Corpuz, G.P.; Abogadie, F.C.; Mena, E.E.; Woodward, S.R.; Hillyard, D.R.; Cruz, L.J. Diversity of Conus neuropeptides. Science, 1990, 249, 257-263.
[8]
Woodward, S.R.; Cruz, L.J.; Olivera, B.M.; Hillyard, D.R. Constant and hypervariable regions. EMBO J., 1990, 9, 1015-1020.
[9]
Olivera, B.M.E.E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology. Mol. Biol. Cell, 1997, 8, 2101-2109.
[10]
Jimenez, E.C.; Craig, A.G.; Watkins, M.; Hillyard, D.R.; Gray, W.R.; Gulyas, J.; Rivier, J.E.; Cruz, L.J.; Olivera, B.M. Bromocontryphan: Post-translational bromination of tryptophan. Biochemistry, 1997, 36, 989-994.
[11]
Jimenez, E.C.; Olivera, B.M.; Gray, W.R.; Cruz, L.J. Contryphan is a D-tryptophan-containing Conus peptide. J. Biol. Chem., 1996, 271, 28002-28005.
[12]
Craig, A.G.; Jimenez, E.C.; Dykert, J.; Nielsen, D.B.; Gulyas, J.; Abogadie, F.C.; Porter, J.; Rivier, J.E.; Cruz, L.J.; Olivera, B.M.; McIntosh, J.M. A novel post-translational modification involving bromination of tryptophan: Identification of the residue, L-6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom. J. Biol. Chem., 1997, 272, 4689-4698.
[13]
Jimenez, E.C.; Watkins, M.; Olivera, B.M. Multiple 6-bromotryptophan residues in a sleep-inducing peptide. Biochemistry, 2004, 43, 12343-12348.
[14]
England, L.J.; Imperial, J.; Jacobsen, R.; Craig, A.G.; Gulyas, J.; Akhtar, M.; Rivier, J.; Julius, D.; Olivera, B.M. Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science, 1998, 281, 575-578.
[15]
Rigby, A.C.; Lucas-Meunier, E.; Kalume, D.E.; Czerwiec, E.; Hambe, B.; Dahlqvist, I.; Fossier, P.; Baux, G.; Roepstorff, P.; Balejai, J.D.; Furie, B.C.; Furie, B.; Stenflo, J. A conotoxin from Conus textile with unusual posttranslational modifications reduces presynaptic Ca21 influx. Proc. Natl. Acad. Sci. USA, 1999, 96, 5758-5763.
[16]
Walker, C.S.; Steel, D.; Jacobsen, R.B.; Lirazan, M.B.; Cruz, L.J.; Hooper, D.; Shetty, R.; Dela Cruz, R.C.; Nielsen, J.S.; Zhou, L.M.; Bandyopadhyay, P.; Craig, A.G.; Olivera, B.M. The T-superfamily conotoxins. J. Biol. Chem., 1999, 274, 30664-30671.
[17]
Czerwiec, E.; Kalume, D.E.; Roepstorff, P.; Hambe, B.; Furie, B.; Furie, B.C.; Stenflo, J. Novel gamma-carboxyglutamic acid-containing peptides from the venom of Conus textile. FEBS J., 2006, 273, 2779-2788.
[18]
Aguilar, M.B.; López-Vera, E.; Ortiz, E.; Becerril, B.; Possani, L.D.; Olivera, B.M.; Heimer de la Cotera, E.P. A novel conotoxin from Conus delessertii with posttranslationally modified lysine residues. Biochemistry, 2005, 44, 11130-11136.
[19]
Jakubowski, J.A.; Kelley, W.P.; Sweedler, J.V. Screening for post-translational modifications in conotoxins using liquid chromatography/mass spectrometry: An important component of conotoxin discovery. Toxicon, 2006, 47, 688-699.
[20]
Nair, S.S.; Nilsson, C.L.; Emmett, M.R.; Schaub, T.M.; Gowd, K.H.; Thakur, S.S.; Krishnan, K.S.; Balaram, P.; Marshall, A.G. De novo sequencing and disulfide mapping of a bromotryptophan-containing conotoxin by Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem., 2006, 78, 8082-8088.
[21]
Nguyen, B.; Caer, J.P.; Mourier, G.; Thai, R.; Lamthanh, H.; Servent, D.; Benoit, E.; Molgó, J. Characterization of a novel Conus bandanus conopeptide belonging to the M-superfamily containing bromotryptophan. Mar. Drugs, 2014, 12, 3449-3465.
[22]
Vijayasarathy, M.; Balaram, P. Mass spectrometric identification of bromotryptophan containing conotoxin sequences from the venom of C. amadis. Toxicon, 2018, 144, 68-74.
[23]
Taylor, S.W.; Kammerer, B.; Nicholson, G.J.; Pusecker, K.; Walk, T.; Bayer, E.; Scippa, S.; de Vincentiis, M. Morulin Pm: A modified polypeptide containing TOPA and 6-bromotryptophan from the morula cells of the ascidian, Phallusia mammillata. Arch. Biochem. Biophys., 1997, 348, 278-288.
[24]
Taylor, S.W.; Craig, A.G.; Fischer, W.H.; Park, M.; Lehrer, R.I. Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. J. Biol. Chem., 2000, 275, 38417-38426.
[25]
Uzzell, T.; Stolzenberg, E.D.; Shinnar, A.E.; Zasloff, M. Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides, 2003, 24, 1655-1667.
[26]
Shinnar, A.E.; Butler, K.L.; Park, H.J. Cathelicidin family of antimicrobial peptides: Proteolytic processing and protease resistance. Bioorg. Chem., 2003, 31, 425-436.
[27]
Tasiemski, A.; Schikorski, D.; Le-Marrec-Croq, F.; Pontoire-Van Camp, C.; Boidin-Wichlacz, C.; Sautière, P.E. Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor. Dev. Comp. Immunol., 2007, 31, 749-762.
[28]
Li, C.; Haug, T.; Styrvold, O.B.; Jørgensen, T.Ø.; Stensvåg, K. Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev. Comp. Immunol., 2008, 32, 1430-1440.
[29]
Solstad, R.G.; Li, C.; Isaksson, J.; Johansen, J.; Svenson, J.; Stensvåg, K.; Haug, T. Novel antimicrobial peptides Eecentrocins 1, 2 and Eestrongylocin 2 from the edible sea urchin Echinus esculentus have 6-Br-Trp post-translational modifications. PLoS One, 2016, 11, e0151820.
[30]
Li, C.; Haug, T.; Moe, M.K.; Styrvold, O.B.; Stensvåg, K. Centrocins: Isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev. Comp. Immunol., 2010, 34, 959-968.
[31]
Fusetani, N.; Sugawara, T.; Matsunaga, S.; Orbiculamide, A. A novel cytotoxic cyclic peptide from a marine sponge Theonela sp. J. Am. Chem. Soc., 1991, 113, 7811-7812.
[32]
Kobayashi, J.; Sato, M.; Murayama, T.; Ishibashi, M.; Walchi, M.R.; Kanai, M.; Shoji, J.; Ohizumi, Y. Konbamide, a novel peptide with calmodulin antagonistic activity from the Okinawan marine sponge Theonella sp. J. Chem. Soc. Chem. Commun., 1991, 15, 1050-1052.
[33]
Zabriskie, T.M.; Klocke, J.A.; Ireland, C.M.; Marcus, A.H.; Molinski, T.F.; Faulkner, D.J.; Xu, C.; Clardy, J.C. Jaspamide, a modified peptide from a Jaspis sponge with insecticidal and antifungal activity. J. Am. Chem. Soc., 1986, 108, 3123-3124.
[34]
Ebada, S.S.; Wray, V.; de Voogd, N.J.; Deng, Z.; Lin, W.; Proksch, P. Two new jaspamide derivatives from the marine sponge Jaspis splendens. Mar. Drugs, 2009, 7, 435-444.
[35]
Watts, K.; Morinaka, B.I.; Amagata, T.; Robinson, S.J.; Tenney, K.; Bray, W.M.; Gassner, N.C.; Lokey, R.S.; Media, J.; Valeriote, F.A.; Crews, P. The biostructural features of additional jasplakinolide (jaspamide) analogues. J. Nat. Prod., 2011, 74, 341-351.
[36]
Clark, W.D.; Corbett, T.; Valeriote, F.; Crews, P. Cylcocinamide A, an unusual cytotoxic halogenated hexapeptide from the marine sponge Psammocinia. J. Am. Chem. Soc., 1997, 119, 9285-9286.
[37]
Sjögren, M.; Göransson, U.; Johnson, A.L.; Dahlström, M.; Andersson, R.; Bergman, J.; Jonsson, P.R.; Bohlin, L. Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. J. Nat. Prod., 2004, 67, 368-372.
[38]
Hedner, E.; Sjögren, M.; Frändberg, P.A.; Johansson, T.; Göransson, U.; Dahlström, M.; Jonsson, P.; Nyberg, F.; Bohlin, L. Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands. J. Nat. Prod., 2006, 69, 1421-1424.
[39]
Hedner, E.; Sjögren, M.; Hodzic, S.; Andersson, R.; Göransson, U.; Jonsson, P.R.; Bohlin, L. Antifouling activity of a dibrominated cyclopeptide from the marine sponge Geodia barretti. J. Nat. Prod., 2008, 71, 330-333.
[40]
Azumi, K.; Yokosawa, H.; Ishii, S. Halocyamines: Novel antimicrobial tetrapeptide-like substances isolated from the hemocytes of the solitary ascidian Halocynthia roretzi. Biochemistry, 1990, 29, 159-165.
[41]
Swersey, J.; Ireland, C.; Cornell, L.; Petersen, R. Eusynstyelamide, a highly modified dimer peptide from the ascidian Eusynstyela misakiens. J. Nat. Prod., 1994, 57, 842-845.
[42]
Tapiolas, D.M.; Bowden, B.F.; Abou-Mansour, E.; Willis, R.H.; Doyle, J.R.; Muirhead, A.N.; Liptrot, C.; Llewellyn, L.E.; Wolff, C.W.; Wright, A.D.; Motti, C.A.; Eusynstyelamides, A. B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius. J. Nat. Prod., 2009, 72, 1115-1120.
[43]
Won, T.H.; Kim, C.K.; Lee, S.H.; Rho, B.J.; Lee, S.K.; Oh, D.C.; Oh, K.B.; Shin, J. Amino acid-derived metabolites from the Ascidian Aplidium sp. Mar. Drugs, 2015, 13, 3836-3848.
[44]
Lehrer, R.I.; Andrew Tincu, J.; Taylor, S.W.; Menzel, L.P.; Waring, A.J. Natural peptide antibiotics from tunicates: Structures, functions and potential uses. Integr. Comp. Biol., 2003, 43, 313-322.
[45]
Fotie, J.; Morgan, R.E. Depsipeptides from microorganisms: A new class of antimalarials. Med. Chem., 2008, 8, 1088-1094.
[46]
Zheng, L.H.; Wang, Y.J.; Sheng, J.; Wang, F.; Zheng, Y.; Lin, X.K.; Sun, M. Antitumor peptides from marine organisms. Mar. Drugs, 2011, 9, 1840-1859.
[47]
Negi, B.; Kumar, D.; Rawat, D.S. Marine peptides as anticancer agents: A remedy to mankind by nature. Curr. Protein Pept. Sci., 2017, 18, 885-904.
[48]
Theiler, R.; Cook, J.C.; Hager, L.P.; Siuda, J.F. Halohydrocarbon synthesis by bromoperoxidase. Science, 1978, 202, 1094-1096.
[49]
Butler, A.; Carter-Franklin, J.N. The role of vanadium bromoperoxidase in the biosynthesis of halogenated marine natural products. Nat. Prod. Rep., 2004, 21, 180-188.
[50]
Wever, R.; Krenn, B.E.; Renirie, R. Marine vanadium-dependent haloperoxidases, their isolation, characterization, and application. Methods Enzymol., 2018, 605, 141-201.
[51]
Welinder, B.S. Halogenated tyrosines from the cuticle of Limulus polyphemus (L.). Biochim. Biophys. Acta, 1972, 279, 49-497.
[52]
Hunt, S.; Breuer, S.W. Chlorinated and brominated tyrosine residues in molluscan scleroprotein. Biochem. Soc. Trans., 1973, 1, 215-216.
[53]
Niemann, H.; Marmann, A.; Lin, W.; Proksch, P. Sponge derived bromotyrosines: Structural diversity through natural combinatorial chemistry. Nat. Prod. Commun., 2015, 10, 219-231.
[54]
Li, C.; Shi, D. Structural and bioactive studies of halogenated constituents from sponges. Curr. Med. Chem., 2018. [Epub ahead of print].
[55]
Fahy, E.; Potts, B.C.M.; Faulkner, D.J. Bromotryptamine derivatives from the tunicate Didemnum candidum. J. Nat. Prod., 1991, 54, 564-569.
[56]
Holst, P.B.; Anthoni, U.; Christophersen, C.; Nielsen, P.H. Marine alkaloids, 16.’ reversible conversion of flustramine B N-1-oxide to flustrarine B. J. Nat. Prod., 1994, 57, 1310-1312.
[57]
Inoue, S.; Okada, K.; Tanino, H.; Hashizume, K.; Kakoi, H. Total synthesis of (±)-surugatoxin. Tetrahedron, 1994, 50(9), 2729-2752.
[58]
Longeon, A.; Copp, B.R.; Quévrain, E.; Roué, M.; Kientz, B.; Cresteil, T.; Petek, S.; Debitus, C.; Bourguet-Kondracki, M.L. Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp. Mar. Drugs, 2011, 9, 879-888.
[59]
Kochanowska-Karamyan, A.J.; Hamann, M.T. Marine indole alkaloids: Potential new drug leads for the control of depression and anxiety. Chem. Rev., 2010, 110, 4489-4497.
[60]
Ibrahim, M.A.; El-Alfy, A.T.; Ezel, K.; Radwan, M.O.; Shilabin, A.G.; Kochanowska-Karamyan, A.J.; Abd-Alla, H.I.; Otsuka, M.; Hamann, M.T. Marine inspired 2-(5-halo-1H-indol-3-yl)-N,N-dimethylethanamines as modulators of serotonin receptors: An example illustrating the power of bromine as part of the uniquely marine chemical space. Mar. Drugs, 2017, 15, E248.
Related Books
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 2)
Micropropagation of Medicinal Plants
Software and Programming Tools in Pharmaceutical Research
Biotechnology and Drug Development for Targeting Human Diseases
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 1)
Molecular and Physiological Insights into Plant Stress Tolerance and Applications in Agriculture- Part 2
Micropropagation of Medicinal Plants
Genome Editing in Bacteria (Part 1)
Data Science for Agricultural Innovation and Productivity
Animal Models In Experimental Medicine
Article Metrics
46
12